Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why BioNTech Stock Slumped Today

TheMotleyFool

0 0

Shares of BioNTech (NASDAQ: BNTX) were slumping 7.5% lower as of 3:35 p.m. EST on Thursday. This decline might seem surprising considering the good news the company and its partner Pfizer (NYSE: PFE) reported this week. This news notably includes positive efficacy results for coronavirus vaccine candidate BNT162b2 and a supply agreement with the European Union for 200 million doses of the vaccine.

Why did the German biotech stock sink? The most likely reason is old-fashioned profit-taking. BioNTech skyrocketed more than 50% in three days after the interim efficacy results were announced for BNT162b2. It's tempting for investors to take profits off the table with a sharp, quick gain like that.

Image source: Getty Images.

Source Fool.com

Like: 0

BNTX

Share